Profile
Full Name
Altimmune, Inc.Ticker
NASDAQ: ALTExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 26, 2017Indexes
Not includedWebsite
https://altimmune.comEmployees
59Key Details
Price
$5.10(6.03%)
Market Cap
$532.15M(Small cap)
Last Dividend
$873.01
Annual Revenue
$20.00K(-95.31% YoY)
Annual EPS
-$1.34(19.40% YoY)
Next earnings date
Feb 26, 2026Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Events
Dividend per share
Dividend yield
Other
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Nov 7, 25 Citizens
Market OutperformOct 20, 25 HC Wainwright & Co.
BuyOct 10, 25 HC Wainwright & Co.
BuyAug 13, 25 UBS
BuyAug 13, 25 HC Wainwright & Co.
BuyAug 13, 25 B. Riley Securities
BuyJul 10, 25 JMP Securities
Market OutperformJun 27, 25 HC Wainwright & Co.
BuyApr 3, 25 HC Wainwright & Co.
BuyApr 2, 25 Citizens Capital Markets
Market OutperformInstitutional Ownership
- What is the ticker symbol for Altimmune, Inc.?
- Does Altimmune, Inc. pay dividends?
- What sector is Altimmune, Inc. in?
- What industry is Altimmune, Inc. in?
- What country is Altimmune, Inc. based in?
- When did Altimmune, Inc. go public?
- Is Altimmune, Inc. in the S&P 500?
- Is Altimmune, Inc. in the NASDAQ 100?
- Is Altimmune, Inc. in the Dow Jones?
- When was Altimmune, Inc.'s last earnings report?
- When does Altimmune, Inc. report earnings?
What is the ticker symbol for Altimmune, Inc.?
The ticker symbol for Altimmune, Inc. is NASDAQ:ALT
Does Altimmune, Inc. pay dividends?
No, Altimmune, Inc. does not pay dividends
What sector is Altimmune, Inc. in?
Altimmune, Inc. is in the Healthcare sector
What industry is Altimmune, Inc. in?
Altimmune, Inc. is in the Biotechnology industry
What country is Altimmune, Inc. based in?
Altimmune, Inc. is headquartered in United States
When did Altimmune, Inc. go public?
Altimmune, Inc.'s initial public offering (IPO) was on May 26, 2017
Is Altimmune, Inc. in the S&P 500?
No, Altimmune, Inc. is not included in the S&P 500 index
Is Altimmune, Inc. in the NASDAQ 100?
No, Altimmune, Inc. is not included in the NASDAQ 100 index
Is Altimmune, Inc. in the Dow Jones?
No, Altimmune, Inc. is not included in the Dow Jones index
When was Altimmune, Inc.'s last earnings report?
Altimmune, Inc.'s most recent earnings report was on November 6, 2025
When does Altimmune, Inc. report earnings?
The next expected earnings date for Altimmune, Inc. is February 26, 2026